Information on pharmacovigilance reporting in the European Union

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2012年 / 1420卷 / 1期
关键词：
Public Health; Annual Report; Economic Area; Pharmacovigilance Reporting;
D O I：
10.2165/00128415-201214200-00016
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4 / 4
相关论文
共 50 条
  • [1] European Union pharmacovigilance capabilities: potential for the new legislation
    Borg, John Joseph
    Tanti, Amy
    Kouvelas, Dimitrios
    Lungu, Calin
    Pirozynski, Michal
    Serracino-Inglott, Anthony
    Aislaitner, George
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2015, 6 (04) : 120 - 140
  • [2] Getting to grips with the new European Union pharmacovigilance legislation
    Waller, Patrick
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (05) : 544 - 549
  • [3] Experiential Learning in Reporting the European Union
    Nistor, Cristina
    Beuran, Rares
    TRANSYLVANIAN REVIEW, 2017, 26 : 91 - 101
  • [4] SUSTAINABILITY REPORTING IN EUROPEAN UNION COMPANIES
    Jovanovic, Dejan
    Bonic, Ljiljana
    Mijic, Kristina
    FRESENIUS ENVIRONMENTAL BULLETIN, 2021, 30 (04): : 3478 - 3487
  • [5] Key pharmacovigilance stakeholders' experiences of direct patient reporting of adverse drug reactions and their prospects of future development in the European Union
    Inacio, P.
    Cavaco, A.
    Allan, E.
    Airaksinen, M.
    PUBLIC HEALTH, 2018, 155 : 119 - 128
  • [6] Veterinary pharmacovigilance. Part 2. Veterinary pharmacovigilance in practice - the operation of a spontaneous reporting scheme in a European Union country - the UK, and schemes in other countries
    Woodward, KN
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2005, 28 (02) : 149 - 170
  • [7] Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives
    Jose, Jobin
    Rafeek, Naziya Refi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (06) : 781 - 786
  • [8] Current state of biologic pharmacovigilance in the European Union: improvements are needed
    Felix, Thomas
    Jordan, John B.
    Akers, Catherine
    Patel, Bina
    Drago, Daniela
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (03) : 231 - 240
  • [9] Pharmacovigilance in India in Comparison With the USA and European Union: Challenges and Perspectives
    Jobin Jose
    Naziya Refi Rafeek
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 781 - 786
  • [10] FINANCIAL REPORTING IN THE EUROPEAN UNION - A COMPARATIVE VIEW
    Klikovac, Ana
    EKONOMSKI PREGLED, 2007, 58 (3-4): : 205 - 223
12345